España
India
Italia
대한민êµ
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Edge
Benzinga Research
Benzinga Pro
Log In
Get Benzinga Pro
Data & APIs
Events
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민êµ
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
US Physical Therapy
USPH
NYSE
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$91.87
1.61
1.78%
At close: -
$91.87
0.00
0.00%
After Hours: 4:00 PM EDT
Get Report
Comment
US Physical Therapy (USPH) Forecast
News
Earnings
US Physical Therapy (USPH) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Government Trades
Short Interest
Latest news for US Physical Therapy (NYSE:USPH) Stock
US Physical Therapy Stock (NYSE: USPH)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Tuesday, December 17, 2024
US Physical Therapy Positioned For Success Despite Medicare Challenges, Analyst Optimistic On Unique Growth Strategy
Vandana Singh
Monday, December 16, 2024
This Addus HomeCare Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday
Avi Kapoor
B of A Securities Upgrades US Physical Therap...
Benzinga Newsdesk
JMP Securities Initiates Coverage On US Physi...
Benzinga Newsdesk
Tuesday, December 03, 2024
Unveiling 6 Analyst Insights On US Physical Therapy
Benzinga Insights
JP Morgan Maintains Overweight on US Physical...
Benzinga Newsdesk
Monday, December 02, 2024
U.S. Physical Therapy Acquired A 75% Interest...
Benzinga Newsdesk
Thursday, November 21, 2024
Barrington Research Maintains Outperform on U...
Benzinga Newsdesk
Wednesday, November 13, 2024
COO Of US Physical Therapy Makes $166K Sale
Benzinga Insights
Thursday, November 07, 2024
Assessing US Physical Therapy: Insights From 5 Financial Analysts
Benzinga Insights
Barrington Research Maintains Outperform on U...
Benzinga Newsdesk
Wednesday, November 06, 2024
US Physical Therapy shares are trading higher...
Benzinga Newsdesk
Tuesday, November 05, 2024
US Physical Therapy Q3 2024 Adj. EPS $0.69 Be...
Benzinga Newsdesk
Monday, November 04, 2024
Exploring US Physical Therapy's Earnings Expectations
Benzinga Insights
Wednesday, October 09, 2024
Barrington Research Maintains Outperform on U...
Benzinga Newsdesk
Monday, October 07, 2024
U.S. Physical Therapy Announces That It Has S...
Benzinga Newsdesk
Stocks Fall As Oil Prices Spike, 10-Year Yields Top 4%, Energy Sector Outperforms: What's Driving Markets Monday?
Piero Cingari
B of A Securities Downgrades US Physical Ther...
Benzinga Newsdesk
Friday, September 20, 2024
Barrington Research Maintains Outperform on U...
Benzinga Newsdesk
Wednesday, September 04, 2024
$1.5M Bet On Elastic? Check Out These 4 Stocks Executives Are Buying
Avi Kapoor
Tuesday, September 03, 2024
U.S. Physical Therapy Acquires A Physical The...
Benzinga Newsdesk
Thursday, August 22, 2024
COO Of US Physical Therapy Makes $142K Sale
Benzinga Insights
Tuesday, August 20, 2024
Concentra's Post-IPO Trading Levels Based On 'Its Dominant Market Position,' Says Analyst
Vandana Singh
Thursday, August 15, 2024
Barrington Research Maintains Outperform on U...
Benzinga Newsdesk
Tuesday, August 13, 2024
U.S. Physical Therapy Returned Its Guidance F...
Benzinga Newsdesk
US Physical Therapy Q2 Adj $0.73 Misses $0.82...
Benzinga Newsdesk
Friday, July 26, 2024
AMED vs. USPH: Which Stock Is the Better Value Option?
Zacks
Thursday, May 09, 2024
Barrington Research Maintains Outperform on U...
Benzinga Newsdesk
Tuesday, May 07, 2024
U.S. Physical Therapy Sees 2024 Adj. EBITDA $...
Benzinga Newsdesk
US Physical Therapy Q1 2024 Adj EPS $0.51 Mis...
Benzinga Newsdesk
Wednesday, May 01, 2024
U.S. Physical Therapy Announces Acquisition O...
Benzinga Newsdesk
Monday, April 01, 2024
US Physical Therapy Announces Acquisition of ...
Benzinga Newsdesk
Friday, March 15, 2024
Chief Financial Officer Of US Physical Therapy Makes $193K Sale
Benzinga Insights
Wednesday, March 13, 2024
JP Morgan Maintains Overweight on US Physical...
Benzinga Newsdesk
Monday, March 11, 2024
U.S. Physical Therapy Announces Change In Med...
Benzinga Newsdesk
Wednesday, March 06, 2024
US Physical Therapy's Ex-Dividend Date Is Monday, Here's What You Need To Know
Benzinga Insights
Friday, March 01, 2024
Barrington Research Maintains Outperform on U...
Benzinga Newsdesk
Wednesday, February 28, 2024
US Physical Therapy Q4 2023 Adj EPS $0.59 Bea...
Benzinga Newsdesk
Earnings Scheduled For February 28, 2024
Benzinga Insights
Wednesday, January 03, 2024
Barrington Research Maintains Outperform Rating for US Physical Therapy: Here's What You Need To Know
Benzinga Insights
Barrington Research Maintains Outperform on U...
Benzinga Newsdesk
Friday, December 15, 2023
Massive Insider Trade At US Physical Therapy
Benzinga Insights
Friday, November 17, 2023
JP Morgan Maintains Overweight on US Physical...
Benzinga Newsdesk
US Physical Therapy COO Trades Company's Stock
Benzinga Insights
Tuesday, November 14, 2023
US Physical Therapy Insider Trades Send a Signal
Benzinga Insights
Thursday, November 09, 2023
Barrington Research Maintains Outperform on U...
Benzinga Newsdesk
Tuesday, November 07, 2023
U.S. Physical Therapy Expects The Company's A...
Benzinga Newsdesk
US Physical Therapy Q3 EPS $0.62 Beats $0.61 ...
Benzinga Newsdesk
Earnings Scheduled For November 7, 2023
Benzinga Insights
Wednesday, November 01, 2023
US Physical Therapy Announces Acquisition Of ...
Benzinga Newsdesk
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch